Back to Office Vaccination Policy Guidance | Nelson Mullins Riley & Scarborough LLP jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Reply
June 2, 2021
Previously, the Equal Employment Opportunity Commission (EEOC) issued Guidance permitting employers to implement COVID-19 vaccine mandates, subject to certain exemptions. The new Guidance reiterates the medical/disability condition and sincerely held religious belief exemptions that the EEOC recognizes for other vaccines.
Subscribe
The EEOC issued Guidance regarding this on May 28 in updates to Section K of their Frequently Asked Questions(FAQ). The May 2021 Guidance does not change in substance from the original Guidance and also addresses new subjects, including incentives under the ADA in K.16 and under the GINA in K.18. As before, the EEOC does not take a position on the FDA s Emergency Use Authorizations (EUA) status.
This shot-in-the-arm gene treatment should be seen AS AN EXTENSION of genetic research into altering humans.
Because thatâs what it is.
The field of gene research includes âcreating better humansâ and eugenics.
Eugenics involves what American Rockefeller and Nazi researchers were setting up: depopulation; population control; selecting out âsuperior genetic strainsâ for survival.
Bring on the angels and trumpets. Bring on the cash
(Jon’s mega-collection,
William Engdahl and Dr. Peter Breggin have done excellent historical analysis of the eugenics movement.
Another point: In recent articles, Iâve pointed out that ALL genetic research -beyond its motives -is also fraught with unintended ripple-effect consequences. Never believe that the targets and the consequences can be contained.
ResearchAndMarkets.com s offering.
This new edition of the report addresses the impact of COVID-19 on telehealth markets, including both devices and services. Includes COVID-19 Impact, COVID-19 Recovery Year Estimates, the result of detailed analysis of secondary information and conversations with vendors.
The base year is 2020, with forecasts provided for each year through 2025. The market was evaluated via a combination of disease prevalence trends, population trends, device innovations, federal and industry standards and regulations, global penetration, economic influences and other macro and micro indicators.
The global patient monitoring and telehealth market has continued its expansion in both the institutional and home segments of the health market with the United States and many European countries at the forefront of implementation.
Published: May 11, 2021
BILLERICA, Mass. (BUSINESS WIRE) Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it has named Masoud Toloue to the position of President of Quanterix and Diagnostics, effective June 9, 2021.
“We are excited to welcome Masoud to our team at such an important moment for Quanterix,” said Kevin Hrusovsky, Chairman and Chief Executive Officer Quanterix. “We are making important strides in advancing our diagnostic capability and assays, given the NIH RADx funding, our COVID-19 Emergency Use Authorizations and advances in our neurology suite of assays for Multiple Sclerosis, Alzheimer’s and Parkinson’s research as well as phase III drug trials. Masoud’s strong growth track record of doubling PerkinElmer’s diagnostics franchise, wealth of experience, deep roots in the life sciences and business acumen will be instrumental a